|
|
Volumn 14, Issue 7, 2008, Pages 991-993
|
|
Venous thromboembolism with inflammatory bowel disease
|
|
Author keywords
Crohn's disease; Inflammatory bowel disease; Thromboembolism; Ulcerative colitis; Venous thrombosis
|
|
Indexed keywords
5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);
ANTICOAGULANT AGENT;
AZATHIOPRINE;
BLOOD CLOTTING FACTOR 5 LEIDEN;
HEPARIN;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
OLSALAZINE;
ORAL CONTRACEPTIVE AGENT;
PROTHROMBIN;
CROHN DISEASE;
ENTERITIS;
GENETIC POLYMORPHISM;
GENETIC RISK;
GENETIC VARIABILITY;
HUMAN;
REVIEW;
RISK BENEFIT ANALYSIS;
RISK FACTOR;
RISK REDUCTION;
SMOKING CESSATION;
THROMBOCYTE ACTIVATION;
ULCERATIVE COLITIS;
VEIN THROMBOSIS;
VENOUS THROMBOEMBOLISM;
|
|
EID: 40149086238
PISSN: 10079327
EISSN: None
Source Type: Journal
DOI: 10.3748/wjg.14.991 Document Type: Review |
|
Times cited : (17)
|
|
References (28)
|
